| scholarly article | Q13442814 |
| P2093 | author name string | Ji Li | |
| Jun Ren | |||
| Qun Li | |||
| Asli F Ceylan-Isik | |||
| P2860 | cites work | Suppression of aging in mice by the hormone Klotho | Q24650916 |
| TSC2 mediates cellular energy response to control cell growth and survival | Q27860970 | ||
| Effects of human growth hormone in men over 60 years old | Q28288413 | ||
| alpha-Klotho as a regulator of calcium homeostasis | Q28306317 | ||
| IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice | Q29616382 | ||
| Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease | Q33790540 | ||
| Insulin-Like growth factor I: implications in aging | Q33873279 | ||
| Growth hormone and cardiac function | Q33903319 | ||
| Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice | Q34156036 | ||
| Functionally significant insulin-like growth factor I receptor mutations in centenarians | Q34757952 | ||
| Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis | Q35830162 | ||
| IGF-1 and insulin as growth hormones. | Q35962291 | ||
| Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? | Q35994668 | ||
| The role of insulin and IGF-1 signaling in longevity | Q36050369 | ||
| Cardiovascular risk in aging and obesity: is there a role for GH. | Q36309188 | ||
| Metabolic effects of IGF-I deficiency: lessons from mouse models | Q36348502 | ||
| Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways | Q36384266 | ||
| Normal growth and development in the absence of hepatic insulin-like growth factor I | Q36394699 | ||
| Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy | Q37373506 | ||
| Human growth hormone and human aging | Q40906146 | ||
| Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome | Q41022988 | ||
| Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes | Q42479245 | ||
| Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. | Q42484209 | ||
| Cardiac contractile function is enhanced in isolated ventricular myocytes from growth hormone transgenic mice | Q43993473 | ||
| Impaired cardiac excitation-contraction coupling in ventricular myocytes from Ames dwarf mice with IGF-I deficiency | Q44100211 | ||
| Insulin-like growth factor I deficiency prolongs survival and antagonizes paraquat-induced cardiomyocyte dysfunction: role of oxidative stress | Q46917169 | ||
| Klotho protein protects against endothelial dysfunction | Q47799420 | ||
| Cardiac overexpression of metallothionein rescues chronic alcohol intake-induced cardiomyocyte dysfunction: role of Akt, mammalian target of rapamycin and ribosomal p70s6 kinase. | Q53595420 | ||
| Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. | Q53629126 | ||
| Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats | Q73571800 | ||
| Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage | Q79330406 | ||
| Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging | Q82469718 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 725-733 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Rejuvenation Research | Q7310582 |
| P1476 | title | Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction | |
| P478 | volume | 11 |
| Q33825443 | A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3. |
| Q42154599 | AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction |
| Q36649084 | Alpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I. |
| Q33692414 | Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart |
| Q37442678 | Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target? |
| Q33806910 | Cardiac aging in mice and humans: the role of mitochondrial oxidative stress |
| Q35898648 | Cardiac aging: from molecular mechanisms to significance in human health and disease |
| Q54562272 | Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. |
| Q37310637 | Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia |
| Q34474751 | Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: role of AMPK |
| Q36431795 | Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice |
| Q27302985 | GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats |
| Q96303481 | Glucocorticoid Signaling and the Aging Heart |
| Q41112302 | GsMTx4-D is a cardioprotectant against myocardial infarction during ischemia and reperfusion. |
| Q26822806 | Human conditions of insulin-like growth factor-I (IGF-I) deficiency |
| Q35186280 | Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca(2+) homeostasis |
| Q41089202 | Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function |
| Q28072348 | NADPH oxidases: key modulators in aging and age-related cardiovascular diseases? |
| Q42954804 | Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway |
| Q35128583 | Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase |
| Q38571586 | Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system |
| Q28084341 | Quality control systems in cardiac aging |
| Q38578328 | The Aging Heart |
| Q33817029 | The GH/IGF-1 axis in ageing and longevity |
| Q37228131 | The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2. |
| Q37035744 | The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research |
| Q35947431 | The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances |
| Q37381848 | The role of liver-derived insulin-like growth factor-I. |
Search more.